New research published in Annals of Rheumatic Diseases and Hypertension examined the impact medications for different non-cardiovascular conditions can have on a patient's heart health.

Diagnostic catheters, ablation catheters and stents are just some of the solutions cardiologists are now struggling to obtain.

The new-look device gained CE mark approval in Europe in 2020, but it has not been approved yet in the United States.

Researchers examined data from more than 900 patients, presenting their findings in the Journal of the American Heart Association.

Nontraditional risk factors such as dementia, PTSD, bipolar disorder and low socioeconomic status are all important to consider when patients are candidates for aortic valve replacement. 

Medtronic presented the real-world data at the PCR London Valves 2022 conference. The company's Evolut FX TAVR system gained FDA approval back in August 2021. 

Yes, even a little additional salt can make a big impact on a person's cardiovascular health. The full analysis was published in the Journal of the American College of Cardiology.

“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago.